Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Active not recruiting 11Recruiting 8Completed 3Suspended 2Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 234Neoplasms 206Carcinoma, Non-Small-Cell Lung 100Colorectal Neoplasms 98Prostatic Neoplasms 93Lung Neoplasms 78Multiple Myeloma 53Melanoma 51Pancreatic Neoplasms 50Head and Neck Neoplasms 49Neoplasm Metastasis 47Leukemia, Myeloid, Acute 43Carcinoma, Hepatocellular 43Ovarian Neoplasms 39Brain Neoplasms 39Squamous Cell Carcinoma of Head and Neck 36Recurrence 35Glioblastoma 33Uterine Cervical Neoplasms 32Sarcoma 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Glioma 29Lymphoma, Non-Hodgkin 28Lymphoma 27Colonic Neoplasms 27Stomach Neoplasms 26Carcinoma, Renal Cell 26Lymphoma, Follicular 25Esophageal Neoplasms 24Rectal Neoplasms 23

Interventions

ruxolitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Breast Carcinoma In Situ × 90 days × Clear all
NCT04245176 2026-05-04

Genetic Testing for All Breast Cancer Patients (GET FACTS)

Brigham and Women's Hospital

Phase NA Completed
400 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms

NCT02928978 2026-04-13

TBCRC042

Baylor Breast Care Center

Phase 2 Completed
84 enrolled
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT05263362 2026-04-13

STARLINGS

Erasmus Medical Center

Completed
775 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡